Published April, 2022
By Stephen T Holgate, Aziz Sheikh, Stephen Holgate, Khurana, Robyn E. O'Hehir, HOLGATE, Gurjit K. Khurana Hershey, Gurjit K. Hershey, O'Hehir, Sheikh and Gurjit Khurana Hershey
Publisher: Elsevier (Elsevier - Health Sciences Division)
Rating:
Availability: Available
By Stephen T Holgate, Aziz Sheikh, Stephen Holgate, Khurana, Robyn E. O'Hehir, HOLGATE, Gurjit K. Khurana Hershey, Gurjit K. Hershey, O'Hehir, Sheikh and Gurjit Khurana Hershey
Publisher: Elsevier (Elsevier - Health Sciences Division)
Rating:
Availability: Available
Hardback
€126.71
Published April, 2022
By Elizabeth Phillips
Publisher: Elsevier (Elsevier - Health Sciences Division)
Rating:
Availability: Available
By Elizabeth Phillips
Publisher: Elsevier (Elsevier - Health Sciences Division)
Rating:
Availability: Available
Hardback
€99.83
Published April, 2022
By Frederick W Alt and Kenneth M. Murphy
Publisher: Elsevier (Academic Press Inc)
Rating:
Availability: Available
By Frederick W Alt and Kenneth M. Murphy
Publisher: Elsevier (Academic Press Inc)
Rating:
Availability: Available
Hardback
€172.80
Published April, 2022
By Shyam S. Bansal
Publisher: Taylor & Francis (CRC Press)
Rating:
Availability: Available
By Shyam S. Bansal
Publisher: Taylor & Francis (CRC Press)
Rating:
Availability: Available
This book provides detailed information on aspects of inflammation, and the manner in which immune activation pathways affect the progression of cardiovascular diseases and the repair/regeneration mechanisms of underlying diseased tissues.
Hardback
€147.20
Published April, 2022
By Lorna R. Fiedler and Caroline Pellet-Many
Publisher: Springer (Springer-Verlag New York Inc.)
Rating:
Availability: Available
By Lorna R. Fiedler and Caroline Pellet-Many
Publisher: Springer (Springer-Verlag New York Inc.)
Rating:
Availability: Available
This volume provides an updated collection of protocols for manipulating and studying VEGF signaling pathways in vitro and in vivo and aims to present a range of both firmly established and newly emerging technologies.
Hardback
€204.79
Published April, 2022
By Mohammad Shahid, Anuradha Singh and Hiba Sami
Publisher: Springer (Springer Verlag, Singapore)
Rating: 1.00
Availability: Available
By Mohammad Shahid, Anuradha Singh and Hiba Sami
Publisher: Springer (Springer Verlag, Singapore)
Rating: 1.00
Availability: Available
This timely book discusses antimicrobial drug resistance, specifically, the resistance against the beta-lactam class of antibiotics by Gram-Negative bacteria. The last section of the book describes the various therapeutic options to combat this growing public threat of antimicrobial resistance.
Hardback
€153.59
Published April, 2022
By Jun Sun
Publisher: Springer (Springer Nature Switzerland AG)
Rating: 1.00
Availability: Available
By Jun Sun
Publisher: Springer (Springer Nature Switzerland AG)
Rating: 1.00
Availability: Available
Further, the chapters highlight the progress of immune therapy, stem cells and the role of the microbiome in the pathophysiology of cancers.Readers will gain insights into complex microbial communities, that inhabit most external human surfaces and play a key role in health and disease.
Paperback / softback
€166.39
Published April, 2022
By Nima Rezaei and Parnian Jabbari
Publisher: Elsevier (Academic Press Inc)
Rating:
Availability: Available
By Nima Rezaei and Parnian Jabbari
Publisher: Elsevier (Academic Press Inc)
Rating:
Availability: Available
Paperback / softback
€175.36
Published April, 2022
By Peggi Angel and Michael Ostrowski
Publisher: Elsevier (Academic Press Inc)
Rating:
Availability: Available
By Peggi Angel and Michael Ostrowski
Publisher: Elsevier (Academic Press Inc)
Rating:
Availability: Available
Hardback
€152.32
Published April, 2022
By Jamuna A. Bai, Ravishankar V. Rai and JSS AHER
Publisher: Springer (Springer Verlag, Singapore)
Rating:
Availability: Available
By Jamuna A. Bai, Ravishankar V. Rai and JSS AHER
Publisher: Springer (Springer Verlag, Singapore)
Rating:
Availability: Available
It covers the advanced tools of synthetic biology and metabolic engineering including cluster assembly, CRISPR/Cas9 technologies, and chassis strain development for natural product overproduction in Actinomycetes.
Hardback
€230.39